CXI Healthcare Technology Group Resultados de beneficios anteriores
Pasado controles de criterios 4/6
CXI Healthcare Technology Group has been growing earnings at an average annual rate of 70.7%, while the Personal Products industry saw earnings growing at 9.9% annually. Revenues have been declining at an average rate of 7% per year. CXI Healthcare Technology Group's return on equity is 6.1%, and it has net margins of 42.3%.
Información clave
70.7%
Tasa de crecimiento de los beneficios
69.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Personal Products | 3.8% |
| Tasa de crecimiento de los ingresos | -7.0% |
| Rentabilidad financiera | 6.1% |
| Margen neto | 42.3% |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Insufficient Growth At CXI Healthcare Technology Group Limited (KOSDAQ:900120) Hampers Share Price
Sep 30
CXI Healthcare Technology Group (KOSDAQ:900120) Is Experiencing Growth In Returns On Capital
Aug 05Lacklustre Performance Is Driving CXI Healthcare Technology Group Limited's (KOSDAQ:900120) Low P/S
May 30How Much Did CKH Food & Health's(KOSDAQ:900120) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 02Desglose de ingresos y gastos
Cómo gana y gasta dinero CXI Healthcare Technology Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 69,420 | 29,349 | 5,600 | 4,939 |
| 31 Mar 24 | 67,194 | 21,013 | 3,401 | 5,231 |
| 31 Dec 23 | 68,673 | 17,446 | 4,305 | 5,611 |
| 30 Sep 23 | 69,715 | 12,117 | 6,971 | 7,873 |
| 30 Jun 23 | 71,617 | 7,528 | 10,442 | 9,750 |
| 31 Mar 23 | 79,065 | 1,294 | 13,352 | 12,812 |
| 31 Dec 22 | 87,718 | 3,198 | 13,294 | 13,550 |
| 30 Sep 22 | 98,052 | 9,532 | 12,327 | 9,969 |
| 30 Jun 22 | 101,376 | 5,981 | 12,437 | 9,317 |
| 31 Mar 22 | 103,312 | 6,182 | 13,586 | 5,963 |
| 31 Dec 21 | 105,354 | 4,302 | 14,554 | 3,998 |
| 30 Sep 21 | 108,284 | 2,762 | 15,390 | 5,424 |
| 30 Jun 21 | 104,593 | 5,098 | 12,846 | 3,818 |
| 31 Mar 21 | 81,035 | -55,823 | 17,799 | 6,389 |
| 31 Dec 20 | 64,812 | -70,201 | 23,388 | 9,016 |
| 30 Sep 20 | 63,264 | -83,142 | 30,209 | 9,995 |
| 30 Jun 20 | 63,406 | -98,437 | 39,211 | 10,858 |
| 31 Mar 20 | 82,358 | -61,945 | 44,740 | 9,371 |
| 31 Dec 19 | 106,374 | -64,559 | 50,190 | 8,496 |
| 30 Sep 19 | 117,046 | -67,216 | 52,472 | 9,575 |
| 30 Jun 19 | 129,309 | -70,621 | 54,781 | 11,801 |
| 31 Mar 19 | 147,921 | -64,977 | 55,239 | 13,323 |
| 31 Dec 18 | 149,568 | -66,308 | 57,169 | 13,316 |
| 30 Sep 18 | 148,347 | -72,578 | 60,733 | 13,198 |
| 30 Jun 18 | 145,264 | -73,933 | 62,473 | 12,874 |
| 31 Mar 18 | 120,456 | -70,977 | 58,424 | 11,190 |
| 31 Dec 17 | 120,228 | -49,884 | 51,365 | 9,909 |
| 30 Sep 17 | 125,336 | -24,445 | 46,229 | 7,972 |
| 30 Jun 17 | 146,319 | 786 | 41,966 | 6,210 |
| 31 Mar 17 | 190,109 | 18,964 | 47,108 | 6,736 |
| 31 Dec 16 | 228,969 | 29,945 | 54,039 | 7,269 |
| 30 Sep 16 | 269,185 | 42,624 | 57,943 | 7,848 |
| 30 Jun 16 | 297,600 | 52,396 | 62,255 | 8,734 |
| 31 Mar 16 | 311,164 | 60,931 | 61,307 | 8,804 |
| 31 Dec 15 | 318,262 | 66,823 | 58,631 | 9,212 |
| 30 Sep 15 | 321,330 | 71,473 | 58,068 | 9,382 |
| 30 Jun 15 | 317,895 | 73,452 | 55,460 | 9,495 |
| 31 Mar 15 | 312,412 | 69,309 | 56,652 | 9,843 |
| 31 Dec 14 | 303,794 | 68,530 | 52,573 | 9,487 |
| 30 Sep 14 | 291,664 | 65,401 | 49,554 | 9,258 |
| 30 Jun 14 | 286,376 | 63,604 | 48,559 | 8,595 |
| 31 Mar 14 | 285,469 | 66,365 | 45,229 | 7,919 |
| 31 Dec 13 | 279,352 | 62,672 | 45,690 | 7,818 |
Ingresos de calidad: A900120 has a large one-off gain of ₩10.3B impacting its last 12 months of financial results to 30th June, 2024.
Margen de beneficios creciente: A900120's current net profit margins (42.3%) are higher than last year (10.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: A900120 has become profitable over the past 5 years, growing earnings by 70.7% per year.
Acelerando crecimiento: A900120's earnings growth over the past year (289.9%) exceeds its 5-year average (70.7% per year).
Beneficios vs. Industria: A900120 earnings growth over the past year (289.9%) exceeded the Personal Products industry 30.2%.
Rentabilidad financiera
Alta ROE: A900120's Return on Equity (6.1%) is considered low.